835 filings
Page 3 of 42
20-F
2023 FY
KZIA
Kazia Therapeutics Limited
Annual report (foreign)
26 Oct 23
7:56am
6-K
KZIA
Kazia Therapeutics Limited
23 Oct 23
Kazia Therapeutics Announces Clinical Data at Esmo 2023 from Ongoing Phase 1 EVT801 Study
8:30am
6-K
KZIA
Kazia Therapeutics Limited
13 Oct 23
Current report (foreign)
4:08pm
6-K
KZIA
Kazia Therapeutics Limited
11 Oct 23
Kazia Announces Voluntary Delisting from Asx
7:35am
6-K
KZIA
Kazia Therapeutics Limited
10 Oct 23
Current report (foreign)
3:04pm
6-K
KZIA
Kazia Therapeutics Limited
6 Oct 23
Current report (foreign)
7:00am
6-K
KZIA
Kazia Therapeutics Limited
29 Sep 23
Kazia Therapeutics Announces Acceptance of
7:00am
6-K
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
6-K
KZIA
Kazia Therapeutics Limited
11 Aug 23
Kazia Therapeutics Announces Change to Board of Directors
7:00am
6-K
KZIA
Kazia Therapeutics Limited
6 Jul 23
Current report (foreign)
4:15pm
6-K
KZIA
Kazia Therapeutics Limited
26 Jun 23
Kazia Corporate Update and Corporate Presentation
7:00am
6-K
KZIA
Kazia Therapeutics Limited
5 Jun 23
Kazia Expands Board of Directors with Appointment of Ebru Davidson
7:35am
6-K
KZIA
Kazia Therapeutics Limited
1 May 23
Kazia Announces Executive Leadership Changes
7:14am
6-K
KZIA
Kazia Therapeutics Limited
14 Apr 23
Current report (foreign)
7:49am
6-K
KZIA
Kazia Therapeutics Limited
4 Apr 23
Kazia Presents New Data for Paxalisib and EVT801
7:32am
6-K/A
KZIA
Kazia Therapeutics Limited
9 Mar 23
2. Results for announcement to the market
7:32am
6-K
KZIA
Kazia Therapeutics Limited
7 Mar 23
Kazia Therapeutics Announces Clinical Collaboration for Australian Phase Ii Precision Medicine Study of Paxalisib In Childhood Cancers
7:40am
6-K
KZIA
Kazia Therapeutics Limited
28 Feb 23
2. Results for announcement to the market
4:18pm
6-K
KZIA
Kazia Therapeutics Limited
24 Feb 23
Results of Egm
4:30pm
6-K
KZIA
Kazia Therapeutics Limited
24 Feb 23
Current report (foreign)
7:35am